Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-29 @ 11:57 PM
Study NCT ID:
NCT07343518
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-01-15
First Post:
2025-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effects of Sulforaphane Supplementation on Athletic Performance
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2026-03-25'}, 'conditionBrowseModule': {'meshes': [{'id': 'D005221', 'term': 'Fatigue'}], 'ancestors': [{'id': 'D012816', 'term': 'Signs and Symptoms'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR'], 'maskingDescription': 'Both participants and investigator will be blinded to the experimental conditions. Both placebo and supplementation will have the same appearence. Only the outcome assessor will know the assigned sequence to each participant'}, 'primaryPurpose': 'OTHER', 'interventionModel': 'CROSSOVER'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 20}}, 'statusModule': {'overallStatus': 'NOT_YET_RECRUITING', 'startDateStruct': {'date': '2026-01-02', 'type': 'ESTIMATED'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2026-01', 'completionDateStruct': {'date': '2026-05-01', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2026-01-06', 'studyFirstSubmitDate': '2025-12-20', 'studyFirstSubmitQcDate': '2026-01-06', 'lastUpdatePostDateStruct': {'date': '2026-01-15', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2026-01-15', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2026-04-01', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'time to exhaustion', 'timeFrame': '24 hours'}], 'secondaryOutcomes': [{'measure': 'Rating of Fatigue Scale', 'timeFrame': 'Baseline, 30 minutes, 24 hours'}, {'measure': 'Total Quality Recovery Scale', 'timeFrame': 'Baseline, 30 minutes, 24 hours'}, {'measure': 'Muscle soreness (Visual analogue scale)', 'timeFrame': 'Baseline, 30 minutes, 24 hours'}, {'measure': 'Rating of perceived exertion scale', 'timeFrame': '30 minutes'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['sulforaphane', 'fatigue', 'athletic performance'], 'conditions': ['Nutrition', 'Sports']}, 'descriptionModule': {'briefSummary': 'Considering the promising effects observed and the scarce and incipient scientific background of SFN in sports, the present study aims to evaluate the effects of SFN supplementation on fatigue, EIMD and recovery in trained individuals. In particular, outcomes such as time to exhaustion (TTE), and perceptual questionnaires of muscle soreness, recovery, and fatigue will be assessed, aiming to explore the effectiveness of SFN.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '35 Years', 'minimumAge': '18 Years', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Physically active individuals (engaging in exercise 3 or more times per week)\n\nExclusion Criteria:\n\n* Individuals that experience musculoskeletal injuries or have experienced in the past 3 months'}, 'identificationModule': {'nctId': 'NCT07343518', 'briefTitle': 'Effects of Sulforaphane Supplementation on Athletic Performance', 'organization': {'class': 'OTHER', 'fullName': 'University of Maia'}, 'officialTitle': 'Effects of Sulforaphane Supplementation on Athletic Performance: a Double-blinded Randomized Crossover Study', 'orgStudyIdInfo': {'id': 'SFN_001'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Sulforaphane', 'description': 'Sulforaphane supplementation (Nomio)', 'interventionNames': ['Other: Fatigue protocol']}, {'type': 'PLACEBO_COMPARATOR', 'label': 'Placebo', 'description': 'Placebo intervention', 'interventionNames': ['Other: Fatigue protocol']}], 'interventions': [{'name': 'Fatigue protocol', 'type': 'OTHER', 'description': 'Fatigue protocol comprising 6 sets of 30 seconds at 120% of velocity of maximal oxygen consumption', 'armGroupLabels': ['Placebo', 'Sulforaphane']}]}, 'ipdSharingStatementModule': {'ipdSharing': 'UNDECIDED'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'University of Maia', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Principal Investigator', 'investigatorFullName': 'Filipe Silvano Pinto Maia', 'investigatorAffiliation': 'University of Maia'}}}}